Population screening for hereditary and familial cancer syndromes in Valka district of Latvia

Hereditary Cancer in Clinical Practice

Volumn 8, Issue 1, 2010, Pages

  Vanags, Andrejs ^a   Štrumfa, Ilze ^a   Gardovskis, Andris ^a   Borošenko, Viktors ^a   Aboliņš, Arnis ^a   Teibe, Uldis ^a   Trofimovičs, Genadijs ^a   Miklaševičs, Edvins ^a   Gardovskis, Janis ^a  

^a RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER SCREENING; FAMILIAL CANCER; FEMALE; FOUNDER EFFECT; GENE MUTATION; HIGH RISK PATIENT; HUMAN; LATVIA; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; ONSET AGE; OVARY CANCER; RELATIVE; RETROSPECTIVE STUDY; SPOUSE;

EID: 79551544201     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-8-8     Document Type: Article

References (33)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005, 16:481-488. 10.1093/annonc/mdi098, 15718248.
2. Lubiński J, Korzeń M, Górski B, Cybulski C, Debniak T, Jakubowska A, Jaworska K, Wokołorczyk D, Medrek K, Matyjasik J, Huzarski T, Byrski T, Gronwald J, Masojć B, Lener M, Szymańska A, Szymańska-Pasternak J, Serrano-Fernàndez P, Piegat A, Uciński R, Domagała P, Domagała W, Chosia M, Kładny J, Górecka B, Narod S, Scott R. Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology. Breast Cancer Res Treat 2009, 114(1):121-126. 10.1007/s10549-008-9974-8, 18415014.
3. Daly PA. Hereditary cancer: guidelines in clinical practice - general overview. Ann Oncol 2004, 15(Suppl 4):iv121-125.
4. Olopade OI, Pichert G. Cancer genetics in oncology practice. Ann Oncol 2001, 12:895-908. 10.1023/A:1011176107455, 11521793.
5. Federico M, Maiorana A, Mangone L, Turchetti D, Canossi B, Cortesi L, Romagnoli R, Silingardi V. Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal. Breast Cancer Res Treat 1999, 55:213-221. 10.1023/A:1006192230332, 10517166.
6. Hemminki K, Li X. Familial colorectal adenocarcinoma from the Swedish family-cancer database. Int J Cancer 2001, 94:743-748. 10.1002/ijc.1533, 11745471.
7. Imsland AK, Eldon BJ, Arinbjarnarson S, Egilsson V, Tulinius H, Tryggvadóttir L, Arngrimsson R, Magnússon J. Genetic epidemiologic aspects of gastric cancer in Iceland. J Am Coll Surg 2002, 195(2):181-186. 10.1016/S1072-7515(02)01215-2, 12168964.
8. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 2003, 103:525-530. 10.1002/ijc.10863, 12478670.
9. Hemminki K, Li X. Familial risks of cancer as a guide to gene identification and mode of inheritance. Int J Cancer 2004, 110:291-294. 10.1002/ijc.20107, 15069696.
10. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 2005, 93:825-833. 10.1038/sj.bjc.6602769, 2361640, 16160696.
11. Eccles DM. Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics. Ann Oncol 2004, 15(Suppl 4):iv133-iv138.
12. Love RR, Evans AM, Josten DM. The accuracy of patient reports of family history of cancer. J Chronic Dis 1985, 38:289-293. 10.1016/0021-9681(85)90074-8, 3998045.
13. Sweet KM, Bradley TL, Westman JA. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002, 20(2):528-537. 10.1200/JCO.20.2.528, 11786583.
14. Gronwald J, Raczynski A, Tarhoni M, Blachowski M, Huzarski T, Byrski T, Toloczko-Grabarek A, Debniak T, Cybulski C, Huzarska J, Oszurek O, Lubinski J. Population screening for cancer family syndromes in the West Pomeranian region of Poland. Hered Cancer Clin Pract 2006, 4(1):56.
15. Gardovskis A, Irmejs A, Miklasevics E, Borosenko V, Bitina M, Melbarde-Gorkusa I, Vanags A, Kurzawski G, Suchy J, Gorski B, Gardovskis J. Clinical, molecular and geographical features of hereditary breast/ovarian cancer in Latvia. Hered Cancer Clin Pract 2005, 3(2):71-76. 10.1186/1897-4287-3-2-71, 2837301, 20223033.
16. Hampel H, Sweet K, Westman JA, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004, 41:81-91. 10.1136/jmg.2003.010918, 1735676, 14757853.
17. Altman D, Machin D, Bryant T, Gardner S. Statistics with confidence: confidence interval and statistical guidelines 2000, Bristol: BMJ Books, 2.
18. Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska T, Haus O, Janiszewska H, Niepsuj S, Góźdź S, Zaremba L, Posmyk M, Płuzańska M, Kilar E, Czudowska D, Waśko B, Miturski R, Kowalczyk JR, Urbański K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Tołoczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojć B, Mierzejewski M, Narod SA, Lubiński J. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004, 110(5):683-686. 10.1002/ijc.20162, 15146557.
19. Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Wiest JS, Fain P, Schwartz AG, Ypu M, Franklin W, Klein C, Gazdar A, Rothschild H, Mandal D, Coons T, Slusser J, Lee J, Gaba C, Kupert E, Perez A, Zhou X, Zeng D, Liu Q, Zhang Q, Seminara D, Minna J, Anderson MW. A major lung cancer susceptibility locus maps to chromosome 6q23-35. Am J Hum Genet 2004, 75(3):460-474. 10.1086/423857, 1182024, 15272417.
20. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc 2008, 83(5):584-594. 10.4065/83.5.584, 2718421, 18452692.
21. Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, Wisniowski R, Siolek M, Dent R, Lubinski J, Narod S. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol 2010, 28(3):375-379. 10.1200/JCO.2008.20.7019, 20008645.
22. Byrski T, Huzarski T, Dent R, Gronwald J, Zuziak D, Cybulski C, Kladny J, Gorski B, Lubinski J, Narod SA. Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 2009, 115(2):359-363. 10.1007/s10549-008-0128-9, 18649131.
23. Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, Giardiello F, Rodriguez-Bigas MA, Church J, Gruber S, Offit K. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Ann Surg Oncol 2006, 13:1296-1321. 10.1245/s10434-006-9036-6, 16990987.
24. Trimbath JD, Giardiello FM. Review article: genetic testing and counselling for hereditary colorectal cancer. Aliment Pharmacol Ther 2002, 16:1843-1857. 10.1046/j.1365-2036.2002.01357.x, 12390093.
25. Olsson L, Lindblom A. Family history of colorectal cancer in a Sweden county. Fam Cancer 2002, 2(2):87-93.
26. Raedle J, Schaffner M, Esser N, Sahm S, Trojan J, Kriener S, Brieger A, Nier H, Bockhorn H, Berg PL, Frick B, Schäfer D, Zeuzem S. Frequency of the Amsterdam Criteria in a regional German cohort of patients with colorectal cancer. Z Gastroenterol 2002, 40(8):561-568. 10.1055/s-2002-33419, 12297979.
27. Cisco RM, Ford JM, Norton JA. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer 2008, 113(Suppl 7):1850-1856. 10.1002/cncr.23650, 18798546.
28. Tomizawa Y, Adachi J, Kohno T, Yamaguchi N, Saito R, Yokota J. Identification and characterization of families with aggregation of lung cancer. Jpn J Clin Oncol 1998, 28(3):192-195. 10.1093/jjco/28.3.192, 9614442.
29. Bermejo JL, Hemminki K. Familial lung cancer and aggregation of smoking habits: a simulation of the effect of shared environmental factors on the familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2005, 14(7):1738-1740. 10.1158/1055-9965.EPI-05-0201, 16030110.
30. Windsor JA. An update on familial pancreatic cancer and the management of asymptomatic relatives. HPB 2007, 9:4-7. 10.1080/13651820600985325, 2020773, 18333106.
31. Grody WW. Molecular genetic risk screening. Annu Rev Med 2003, 54:473-490. 10.1146/annurev.med.54.101601.152127, 12525682.
32. Guttmacher AE, Collins FS. Population screening in the age of genomic medicine. NEJM 2003, 348(1):50-58. 10.1056/NEJMra013182, 12510043.
33. Tikhomirova L, Sinicka O, Smite D, Eglitis J, Hodgson SV, Stengrevics A. High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia. Fam Cancer 2005, 4:77-84. 10.1007/s10689-004-2758-3, 15951956.